Olema Pharmaceuticals, Inc. (OLMA) Tops Q1 EPS by 18c

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q1 EPS of ($0.36), $0.18 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Are we witnessing a fundamental or speculative rally in the S&P 500?
• Genco Shipping urges shareholders to reject Diana's $24.80 takeover bid